Safety and Efficacy of tPBM for Epileptiform Activity in Autism

PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

April 30, 2026

Study Completion Date

June 30, 2026

Conditions
Autism Spectrum DisorderEEG With Periodic AbnormalitiesEpilepsyNeurodevelopmental DisordersNeurological Disorder
Interventions
DEVICE

noninvasively delivered near infra-red (NIR) light - transcranial Photobiomodulation (tPBM)

The proposed intervention will be noninvasively delivered near infra-red (NIR) light - transcranial Photobiomodulation (tPBM) - to the brains of autistic children. The NIR light is delivered to specific brain areas by Cognilum, a wearable device developed by Jelikalite. The expected outcome is improved focus, improved eye contact, improved speech, improved behavior, and gains in functional skills.

Trial Locations (1)

85050

RECRUITING

Rossignol Medical Center, Phoenix

All Listed Sponsors
lead

Richard Frye

OTHER